US Stock MarketDetailed Quotes

IMUX Immunic

Watchlist
  • 1.000
  • +0.043+4.53%
Close Feb 14 16:00 ET
  • 1.001
  • +0.001+0.06%
Post 20:01 ET
90.08MMarket Cap-0.81P/E (TTM)

About Immunic Company

Immunic, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn’s disease, relapsing-remitting multiple sclerosis, and psoriasis. The firm’s products include IMU-838, IMU-935, and IMU-856. The company is headquartered in New York, NY.

Company Profile

SymbolIMUX
Company NameImmunic
Listing DateApr 17, 2014
Issue Price12.00
Founded2003
CEODr. Daniel Vitt, PhD
MarketNASDAQ
Employees77
Fiscal Year Ends12-31
Address1200 Avenue of the Americas,Suite 200
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10036
Phone1-332-255-9818

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Daniel Vitt, PhD
  • Director and Chief Executive Officer
  • 1.21M
  • Jason Tardio, M.B.A.
  • Chief Operating Officer and President
  • --
  • Patrick Walsh
  • Chief Business Officer
  • --
  • Dr. Andreas Muehler
  • Chief Medical Officer
  • 845.29K
  • Dr. Hella Kohlhof
  • Chief Scientific Officer
  • --
  • Glenn Whaley
  • Chief Financial Officer
  • 702.21K
  • Werner Gladdines
  • Chief Development Officer
  • --
  • Dr. Duane D. Nash, M.D.
  • Executive Chairman of the Board
  • 648.93K
  • Simona Skerjanec, M.B.A.
  • Director
  • --
  • Tamar D. Howson
  • Independent Director
  • 75.97K
  • Richard Alan Rudick
  • Independent Director
  • 95.70K
  • Dr. Jorg Neermann, PhD
  • Independent Director
  • 82.95K
  • Barclay A. Phillips
  • Lead Independent Director
  • 99.16K
  • Monika Maria Tornsen
  • Independent Director
  • 79.67K
  • Inderpal Singh
  • General Counsel
  • --

Trending Stocks

Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.